Morgan M - Search Results

1

GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.

Watson RL, Spalding AC, Zielske SP, Morgan M, Kim AC, Bommer GT, Eldar-Finkelman H, Giordano T, Fearon ER, Hammer GD, Lawrence TS, Ben-Josef E. Watson RL, et al. Among authors: morgan m. Neoplasia. 2010 May;12(5):357-65. doi: 10.1593/neo.92112. Neoplasia. 2010. PMID: 20454507 Free PMC article.

2

The role of Bcl-X(S) in radiation sensitivity.

Morgan MA, Poynter JN, Maybaum J, Lawrence TS. Morgan MA, et al. Radiat Res. 2004 May;161(5):535-9. doi: 10.1667/rr3169. Radiat Res. 2004. PMID: 15161370

3

Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine.

Morgan MA, Parsels LA, Parsels JD, Mesiwala AK, Maybaum J, Lawrence TS. Morgan MA, et al. Cancer Res. 2005 Aug 1;65(15):6835-42. doi: 10.1158/0008-5472.CAN-04-2246. Cancer Res. 2005. PMID: 16061666

4

The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment.

Morgan MA, Parsels LA, Parsels JD, Lawrence TS, Maybaum J. Morgan MA, et al. Cell Cycle. 2006 Sep;5(17):1983-8. doi: 10.4161/cc.5.17.3184. Epub 2006 Sep 1. Cell Cycle. 2006. PMID: 16931916

5

Integration of EGFR inhibitors with radiochemotherapy.

Nyati MK, Morgan MA, Feng FY, Lawrence TS. Nyati MK, et al. Nat Rev Cancer. 2006 Nov;6(11):876-85. doi: 10.1038/nrc1953. Epub 2006 Oct 12. Nat Rev Cancer. 2006. PMID: 17036041 Review.

6

Radiosensitization by gemcitabine fixed-dose-rate infusion versus bolus injection in a pancreatic cancer model.

Morgan M, El Shaikh MA, Abu-Isa E, Davis MA, Lawrence TS. Morgan M, et al. Transl Oncol. 2008 Mar;1(1):44-9. doi: 10.1593/tlo.07118. Transl Oncol. 2008. PMID: 18607504 Free PMC article.

7

Radiotherapy combined with gemcitabine and oxaliplatin in pancreatic cancer cells.

Morgan MA, Meirovitz A, Davis MA, Kollar LE, Hassan MC, Lawrence TS. Morgan MA, et al. Transl Oncol. 2008 Mar;1(1):36-43. doi: 10.1593/tlo.07106. Transl Oncol. 2008. PMID: 18607506 Free PMC article.

8

The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.

Morgan MA, Parsels LA, Kollar LE, Normolle DP, Maybaum J, Lawrence TS. Morgan MA, et al. Clin Cancer Res. 2008 Aug 15;14(16):5142-9. doi: 10.1158/1078-0432.CCR-07-4072. Clin Cancer Res. 2008. PMID: 18698032 Free PMC article.

9

Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review.

Morgan MA, Parsels LA, Maybaum J, Lawrence TS. Morgan MA, et al. Clin Cancer Res. 2008 Nov 1;14(21):6744-50. doi: 10.1158/1078-0432.CCR-08-1032. Clin Cancer Res. 2008. PMID: 18980967 Free PMC article. Review.

10

Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.

Parsels LA, Morgan MA, Tanska DM, Parsels JD, Palmer BD, Booth RJ, Denny WA, Canman CE, Kraker AJ, Lawrence TS, Maybaum J. Parsels LA, et al. Among authors: morgan ma. Mol Cancer Ther. 2009 Jan;8(1):45-54. doi: 10.1158/1535-7163.MCT-08-0662. Mol Cancer Ther. 2009. PMID: 19139112 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,120 results

Search Page

Filters